QLT PhotoTherapeutics Inc., American Home Products deal

The companies revised agreements related to QLTIF's Photofrin light-activated drug to treat cancer. QLTIF

Read the full 142 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE